C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
530/13, 530/15.0
C12N 15/62 (2006.01) A61K 38/17 (2006.01) A61K 38/38 (2006.01) C07K 14/00 (2006.01) C07K 14/47 (2006.01) C07K 14/705 (2006.01) C07K 14/73 (2006.01) C07K 14/76 (2006.01) C07K 14/765 (2006.01) C07K 14/82 (2006.01) C07K 19/00 (2006.01) C12N 15/14 (2006.01) C12N 15/67 (2006.01) C12N 15/81 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2022539
Utilization of albumin as a stable plasma transporter with a therapeutic function that is derived from a membrane receptor. The present invention is exemplified by the description of new therapeutic agents that can be used in the treatment of Acquired Immunodeficiency Syndrome: hybrid macromolecules composed of albumin derivatives coupled to derivatives of the CD4 receptor having a normal or a higher affinity for the HIV-1 virus.
Becquart Jerome
Fleer Reinhard
Hirel Philippe
Klatzmann David
Landais Didier
Novozymes Biopharma Uk Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Rhone-Poulenc Sante
LandOfFree
Albumin derivatives with therapeutic functions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Albumin derivatives with therapeutic functions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Albumin derivatives with therapeutic functions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2084882